Literature DB >> 9048539

The structure of the superantigen exfoliative toxin A suggests a novel regulation as a serine protease.

G M Vath1, C A Earhart, J V Rago, M H Kim, G A Bohach, P M Schlievert, D H Ohlendorf.   

Abstract

Exfoliative toxin A (ETA) causes staphylococcal scalded skin syndrome which is characterized by a specific intraepidermal separation of layers of the skin. The mechanism by which ETA causes skin separation is unknown although protease or superantigen activity has been implicated. The X-ray crystal structure of ETA has been solved in two crystal forms to 2.1 and 2.3 A resolution and R-factors of 17% and 19%, respectively. The structures indicate that ETA belongs to the chymotrypsin-like family of serine proteases and cleaves substrates after acidic residues. The conformation of a loop adjacent to the catalytic site is suggested to be key in regulating the proteolytic activity of ETA through controlling whether the main chain carbonyl group of Pro192 occupies the oxyanion hole. A unique amino-terminal domain containing a 15-residue amphipathic alpha helix may also be involved in protease activation through binding a specific receptor. Substitution of the active site serine residue with cysteine abolishes the ability of ETA to produce the characteristic separation of epidermal layers but not its ability to induce T cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9048539     DOI: 10.1021/bi962614f

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  23 in total

1.  Structural similarities and differences in Staphylococcus aureus exfoliative toxins A and B as revealed by their crystal structures.

Authors:  A C Papageorgiou; L R Plano; C M Collins; K R Acharya
Journal:  Protein Sci       Date:  2000-03       Impact factor: 6.725

2.  Staphylococcal exfoliative toxins cleave alpha- and beta-melanocyte-stimulating hormones.

Authors:  J V Rago; G M Vath; T J Tripp; G A Bohach; D H Ohlendorf; P M Schlievert
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

3.  Recombinant Staphylococcus aureus exfoliative toxins are not bacterial superantigens.

Authors:  L R Plano; D M Gutman; M Woischnik; C M Collins
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

4.  Cleavage isn't everything: potential novel mechanisms of exfoliative toxin-mediated blistering.

Authors:  Takeru Funakoshi; Aimee S Payne
Journal:  Am J Pathol       Date:  2010-11-05       Impact factor: 4.307

5.  Toxin levels in serum correlate with the development of staphylococcal scalded skin syndrome in a murine model.

Authors:  L R Plano; B Adkins; M Woischnik; R Ewing; C M Collins
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

6.  Crystal structure of prethrombin-1.

Authors:  Zhiwei Chen; Leslie A Pelc; Enrico Di Cera
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

Review 7.  Staphylococcal scalded skin syndrome.

Authors:  S Ladhani; R W Evans
Journal:  Arch Dis Child       Date:  1998-01       Impact factor: 3.791

8.  Staphylococcal SplB serine protease utilizes a novel molecular mechanism of activation.

Authors:  Katarzyna Pustelny; Michal Zdzalik; Natalia Stach; Justyna Stec-Niemczyk; Przemyslaw Cichon; Anna Czarna; Grzegorz Popowicz; Pawel Mak; Marcin Drag; Guy S Salvesen; Benedykt Wladyka; Jan Potempa; Adam Dubin; Grzegorz Dubin
Journal:  J Biol Chem       Date:  2014-04-08       Impact factor: 5.157

9.  Identification of the Staphylococcus aureus etd pathogenicity island which encodes a novel exfoliative toxin, ETD, and EDIN-B.

Authors:  Takayuki Yamaguchi; Koji Nishifuji; Megumi Sasaki; Yasuyuki Fudaba; Martin Aepfelbacher; Takashi Takata; Masaru Ohara; Hitoshi Komatsuzawa; Masayuki Amagai; Motoyuki Sugai
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

10.  Molecular mechanisms of blister formation in bullous impetigo and staphylococcal scalded skin syndrome.

Authors:  Yasushi Hanakawa; Norman M Schechter; Chenyan Lin; Luis Garza; Hong Li; Takayuki Yamaguchi; Yasuyuki Fudaba; Koji Nishifuji; Motoyuki Sugai; Masayuki Amagai; John R Stanley
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.